Research & Science
Peer-reviewed publications supporting the science behind Bravo Probiotic Yogurt and imuno® — covering GcMAF, macrophage activation, probiotic diversity, microbiome health, immune function, the gut-brain axis, colostrum, and more.
Showing 23 of 23 publications
Promising role for Gc-MAF in cancer immunotherapy
Thyer L, Ward E, Smith R, et al.
Anticancer Research · 2013
Why it matters: Directly supports Bravo's GcMAF production claim and its role in macrophage activation.
A novel role for a major component of the vitamin D axis: vitamin D binding protein-derived macrophage activating factor induces human breast cancer cell apoptosis through stimulation of macrophages
Pacini S, Morucci G, Punzi T, Ruggiero M, et al.
Nutrients · 2013DOI: 10.3390/nu5072577
Why it matters: Published by Dr. Marco Ruggiero (Bravo's and imuno®'s formulator). Provides mechanistic evidence for GcMAF-mediated immune activation.
GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients
Yamamoto N, Suyama H, Yamamoto N.
OncoImmunology · 2014DOI: 10.4161/onci.25769
Why it matters: Supports the Nagalase/GcMAF relationship described on the Bravo website.
Clinical experience of integrative cancer immunotherapy with GcMAF
Inui T, Kuchiike D, Kubo K, et al.
Anticancer Research · 2013
Why it matters: Clinical evidence for GcMAF's role in immune activation in human patients.
Genetic analysis of Bifidobacteriaceae in a fermented milk and colostrum product in relation to immune function
Carter CJ, Bhatt DL, Bhattacharya S, et al.
American Journal of Immunology and Specialties · 2024
Why it matters: Directly analyzes Bravo's microbial composition and GcMAF activity.
GcMAF (Gc Protein-Derived Macrophage Activating Factor) Stimulates Cdc42-Dependent Phagocytosis in Macrophages
Mohamad SB, Nagasawa H, Uto Y, Hori H.
Journal of Bioscience and Bioengineering · 2002
Why it matters: Foundational mechanistic study establishing how GcMAF activates macrophage phagocytosis — the primary mode of action of imuno®.
Gc Protein-Derived Macrophage-Activating Factor (GcMAF) — A Review of Its Structural, Functional, and Therapeutic Properties
Rehder DS, Nelson RW, Borges CR.
Critical Reviews in Immunology · 2019
Why it matters: Explains the full structural and functional basis of GcMAF and the clinical rationale for supplementing with pre-formed GcMAF as in imuno®.
Chondroitin Sulfate as a Key Regulator of the Complement System and Innate Immunity
Weiss RJ, Esko JD, Tor Y.
Organic & Biomolecular Chemistry · 2017
Why it matters: Supports the inclusion of chondroitin sulfate as a synergistic immune co-factor in the imuno® three-component formulation.
Phosphatidylcholine: A Superior Protectant Against Liver Damage
Küllenberg D, Taylor LA, Schneider M, Massing U.
Lipids in Health and Disease · 2012
Why it matters: Supports phosphatidylcholine as the third component of imuno®, enhancing bioavailability and cellular uptake of GcMAF and chondroitin sulfate.
Sublingual Immunotherapy: Mode of Action and Its Relationship with the Oral Mucosa
Mascarell L, Lombardi V, Louise A, et al.
Immunology · 2008
Why it matters: Provides the scientific basis for imuno®'s sublingual delivery route, explaining why holding imuno® under the tongue maximises immune bioavailability.
Role of the gut microbiota in nutrition and health
Valdes AM, Walter J, Segal E, Spector TD.
BMJ · 2018DOI: 10.1136/bmj.k2179
Why it matters: Foundational evidence that gut microbiome diversity — the core principle behind Bravo's 300+ strain formula — is central to health.
Effects of probiotics on gut microbiota: an overview
Chandrasekaran P, Weiskirchen S, Weiskirchen R.
International Journal of Molecular Sciences · 2024DOI: 10.3390/ijms25116022
Why it matters: Supports the superiority of multi-strain (300+) probiotic formulas over single-strain supplements.
High-biodiversity probiotic promotes liver fibrosis regression: implications for radiotherapy
Ruggiero M, Pacini S.
Preprints · 2024
Why it matters: Directly references Bravo probiotic and its high-biodiversity formula in a clinical context.
Interaction between microbiota and immunity in health and disease
Zheng D, Liwinski T, Elinav E.
Cell Research · 2020DOI: 10.1038/s41422-020-0332-7
Why it matters: Supports the claim that gut microbiome health is foundational to immune system function.
The interplay between the gut microbiome and the immune system in the context of infectious diseases
Belkaid Y, Hand TW.
PMC / Cell · 2021
Why it matters: Mechanistic evidence linking microbiome diversity to immune regulation.
The gut-brain axis: influence of microbiota on mood and mental health
Appleton J.
Integrative Medicine: A Clinician's Journal · 2018
Why it matters: Supports Bravo's gut-brain axis claims and the 95% serotonin statistic.
The correlation between gut microbiota and both neurotransmitter levels and neurodegenerative diseases
Mhanna A, Martini N, Hmaydoosh G, et al.
Medicine · 2023DOI: 10.1097/MD.0000000000036323
Why it matters: Supports the neurological benefits of a diverse, healthy microbiome.
Colostrum therapy for human gastrointestinal health and disease
Chandwe K, Kelly P.
Nutrients · 2021DOI: 10.3390/nu13061956
Why it matters: Supports Bravo's use of colostrum as a fermentation substrate for immune and gut health benefits.
Effects of bovine immunoglobulins on immune function, allergy, and infection
Ulfman LH, Leusen JHW, Savelkoul HFJ, et al.
Frontiers in Nutrition · 2018DOI: 10.3389/fnut.2018.00052
Why it matters: Supports the immunological value of Bravo's colostrum-based substrate.
Short-chain fatty acids: linking diet, the microbiome and immunity
Mann ER, Lam YK, Uhlig HH.
Nature Reviews Immunology · 2024DOI: 10.1038/s41577-024-01014-8
Why it matters: Supports Bravo's claim that its diverse probiotic community produces beneficial SCFAs that support gut and immune health.
Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases
Parada Venegas D, De la Fuente MK, Landskron G, et al.
Frontiers in Immunology · 2019DOI: 10.3389/fimmu.2019.00277
Why it matters: Foundational evidence for the role of SCFA-producing probiotic bacteria in gut health.
Probiotics — compensation for lactase insufficiency
De Vrese M, Stegelmann A, Richter B, et al.
American Journal of Clinical Nutrition · 2001DOI: 10.1093/ajcn/73.2.421s
Why it matters: Supports Bravo's claim that many lactose-intolerant individuals can tolerate the yogurt due to probiotic-produced lactase.
Fermented foods and probiotics: an approach to lactose intolerance
Ibrahim SA, Gyawali R, Awaisheh SS, et al.
Journal of Dairy Research · 2021DOI: 10.1017/S0022029921000625
Why it matters: Supports Bravo's suitability for lactose-intolerant individuals.
Disclaimer: The research listed on this page is provided for educational purposes only. These peer-reviewed publications are cited to support scientific transparency and do not constitute medical advice. Bravo Probiotic Yogurt and imuno® are food/supplement products and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare practitioner before beginning any new health protocol. These statements have not been evaluated by the Food and Drug Administration.